Stay Updated with the Latest Abbott Laboratories ABT News in Real Time
Find ABT news now at Meyka AI. Stay informed with the latest Abbott Laboratories stocks updates, including price news, market analysis, and expert insights.
Stock Market Alert: Will Nifty 50 Hold 24,000 as US-Iran Tensions Push Oil Up 4%?
Nifty 50 faces its next big test as oil prices spike again. Fresh US-Iran hostilities sent Brent crude to $78.67 a barrel on July 13, 2026. WTI crude climbed 3.4% to $73.87. The index closed the previous session at 24,206.90, up 1.02%. Traders are now closely watching whether the Nifty 50 holds above the 24,000…
Trump Fires All 3 Election Assistance Commission Members Before Midterms
Trump fired all three Election Assistance Commission members on July 9, disabling the federal agency that certifies voting systems and helps states run elections before the midterms.
Blue Jet Healthcare (NSE: BLUEJET) Surges 8.5% After Raising ₹800 Crore Through QIP at ₹506 Per Share
Blue Jet Healthcare shares jumped as much as 8.5% on July 10, 2026. The rally followed the company’s ₹800 crore fundraise through a Qualified Institutional Placement. Blue Jet Healthcare allotted 15,810,276 equity shares at ₹506 each, a discount to the floor price. The QIP window ran from July 6 to July 9, 2026, before the…
Dr Reddy’s (NSE: DRREDDY) Shares Tumble 7% After Semaglutide Launch Delay Due to API Quality Issue
Dr Reddy’s Laboratories shares tumbled nearly 7% on Thursday, July 9, 2026, on the NSE. The Hyderabad-based drugmaker disclosed a quality issue affecting its semaglutide active pharmaceutical ingredient. Certain batches were found out of specification, delaying commercial supplies indefinitely. Shares fell as much as 6.5% to an intraday low of ₹1,261.20 on the BSE. That…
Aurobindo Pharma (NSE: AUROPHARMA) Shares Slip Despite US FTC Approval for $250 Million Lannett Acquisition
Aurobindo Pharma shares edged lower on June 22, 2026, despite a significant regulatory win announced before market open. Aurobindo Pharma USA, a wholly-owned subsidiary, received approval from the US Federal Trade Commission to proceed with the $250 million acquisition of Lannett Company LLC on a cash-free, debt-free basis. It inclusive of normalized working capital, with…
Swiss Vegetable Market Faces New Regulatory Hurdles, June 16
Switzerland requires medical device registration and cosmetic compliance by June 2026, affecting vegetable market importers and producers.
Gabbard Declassifies Biolab Records Covering 120+ Facilities, June 15
Tulsi Gabbard declassifies records revealing U.S.-funded biolabs in 30+ countries, including Ukraine, raising oversight questions.
Agilent Technologies (NYSE: A) Climbs After ASMS 2026 Showcase, The Q2 Beat That Changed the Narrative
The story started in a convention center. Agilent Technologies (NYSE: A) showcased its latest integrated mass spectrometry and chromatography innovations at the 74th ASMS Conference on Mass Spectrometry and Allied Topics, held May 31–June 4, 2026, at the San Diego Convention Center in California. The timing was deliberate: Agilent entered ASMS 2026 on the back…
Abbott Laboratories (ABT) Up 6.4% Following European CE Mark Approval of Dual Glucose-Ketone Sensors
Abbott Laboratories recently attracted significant investor attention after receiving European CE Mark approval for its innovative dual glucose-ketone sensor technology. Following the announcement, shares of Abbott Laboratories climbed approximately 6.4 percent, reflecting strong market confidence in the company’s expanding diabetes care portfolio. The approval represents an important step forward in continuous monitoring technology. The new…